The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law BPC 157 and Erectile Dysfunction: What the Evidence Actually Shows BPC 157 Peptide Erectile Dysfunction: Exploring the Research and Real World Use